Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Reconstitution does not apply to oral capsules
If the FDA creates pathways for peptide regulation that acknowledge the growing body of preclinical evidence, compounds like penta deca peptide arginate could move toward formal approval
There is no published pharmacokinetic data in humans, meaning we do not know how the peptide is absorbed, distributed, metabolized, or excreted
Research-grade specs Components: GHK-Cu (50 mg) + BPC-157 (10 mg) + TB-500 (10 mg) + KPV (10 mg) Total strength: 80 mg per vial Format: Lyophilized powder, single-vial blend Pathways studied: Matrix remodelling (GHK-Cu), cell migration (BPC-157, TB-500), cytokine signalling (KPV) Studied applications Multi-pathway combination research Comparative single-compound vs combination studies Receptor and cytokine pathway interaction research Copper-peptide and tripeptide comparative research Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Storage & handling Store lyophilized vials refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water
A healthier liver improves your bodys ability to process nutrients, which is essential for weight management and overall wellness
Research Insights Weight Management and Fat Metabolism Key Findings: AOD-9604 promotes fat loss by stimulating lipolysis and inhibiting lipogenesis in adipose tissue
